Podocyte p53 Limits the Severity of Experimental Alport Syndrome
Open Access
- 1 January 2016
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 27 (1) , 144-157
Abstract
Alport syndrome (AS) is one of the most common types of inherited nephritis caused by mutation in one of the glomerular basement membrane components. AS is characterized by proteinuria at early stage of the disease and glomerular hyperplastic phenotype and renal fibrosis at late stage. Here, we show that global deficiency of tumor suppressor p53 significantly accelerated AS progression in X-linked AS mice and decreased the lifespan of these mice. p53 protein expression was detected in 21-week-old wild-type mice but not in age-matched AS mice. Expression of proinflammatory cytokines and profibrotic genes was higher in p53+/− AS mice than in p53+/+ AS mice. In vitro experiments revealed that p53 modulates podocyte migration and positively regulates the expression of podocyte-specific genes. We established podocyte-specific p53 (pod-p53)-deficient AS mice, and determined that pod-p53 deficiency enhanced the AS-induced renal dysfunction, foot process effacement, and alteration of gene-expression pattern in glomeruli. These results reveal a protective role of p53 in the progression of AS and in maintaining glomerular homeostasis by modulating the hyperplastic phenotype of podocytes in AS.Keywords
This publication has 52 references indexed in Scilit:
- Mechanisms of p53 activation and physiological relevance in the developing kidneyAmerican Journal of Physiology-Renal Physiology, 2012
- The p53 inhibitor pifithrin-α can stimulate fibrosis in a rat model of ischemic acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2012
- Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritisNature Medicine, 2011
- Glomerular pathology in Alport syndrome: a molecular perspectivePediatric Nephrology, 2011
- Inflammation and p53: A Tale of Two StressesGenes & Cancer, 2011
- p53 and its mutants in tumor cell migration and invasionJournal of Cell Biology, 2011
- AMP-activated Protein Kinase (AMPK) Negatively Regulates Nox4-dependent Activation of p53 and Epithelial Cell Apoptosis in DiabetesJournal of Biological Chemistry, 2010
- Anoikis triggers Mdm2-dependent p53 degradationMolecular and Cellular Biochemistry, 2010
- Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndromeJournal of Clinical Investigation, 2010
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002